Bivalirudin
Product Images NDC 75929-217

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 75929-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharma Packaging Solutions, Llc Dba Tjoapack Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Bivalirudin for Injection 250 mg in a box of 10 single-dose vials. The label states this product is for intravenous use only and includes storage instructions to keep at 20 to 25°C with permitted excursions. Distributed by Civica and manufactured by Patheon Italia, Italy. The label includes ingredient information and dosage guidance.*

FDA Label Image

Chemical Structure (Bivalirudin Civica 01)

Chemical structure of bivalirudin showing its detailed molecular composition including peptide bonds, functional groups, and side chains. The image illustrates the complex arrangement of atoms bridging the peptide sequence with annotations for molecular components such as x CF3CO2H with a variable x range from 1.7 to 2.6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.